1. PTU-189 Are the current management strategies for T1/T2 N0 oesophageal cancer optimal?. (28th May 2012) Authors: Evans, J; Pande, R; Beardsmore, D; Corless, D; Crisp, W; Cheruvu, C Journal: Gut Issue: Volume 61(2012)Supplement 2 Page Start: A262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma. Issue 13 (25th September 2017) Authors: Noble, F; Lloyd, M A; Turkington, R; Griffiths, E; O'Donovan, M; O'Neill, J R; Mercer, S; Parsons, S L; Fitzgerald, R C; Underwood, T J; Noorani, A; Fels Elliott, R; Abdullahi, Z; de la Rue, R; Bornschein, J; MacRae, S; Nutzinger, B; Grehan, N; Contino, G; Crawte, J Journal: British journal of surgery Issue: Volume 104:Issue 13(2017) Page Start: 1816 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗